400.30
-5.10
(-1.26%)
At close: January 29 at 4:00:02 PM EST
394.09
-6.21
(-1.55%)
Pre-Market: 8:48:52 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 21 | 19 |
| Avg. Estimate | 10.62 | 10.17 | 34.49 | 39.58 |
| Low Estimate | 9.55 | 9.03 | 30.94 | 35.3 |
| High Estimate | 11.4 | 10.97 | 41.53 | 46.95 |
| Year Ago EPS | 10.64 | 10.12 | 33.04 | 34.49 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 14 | 12 |
| Avg. Estimate | 46.31B | 47.79B | 191.25B | 204.65B |
| Low Estimate | 45.39B | 47.45B | 184.96B | 198.94B |
| High Estimate | 48.23B | 48.31B | 194.57B | 210.05B |
| Year Ago Sales | 42.27B | 43.22B | 175.2B | 191.25B |
| Sales Growth (year/est) | 9.54% | 10.57% | 9.16% | 7.01% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 10.53 | 10.01 | 9.65 | 3.85 |
| EPS Actual | 10.64 | 10.12 | 8.37 | 3.84 |
| Difference | 0.11 | 0.11 | -1.28 | -0.01 |
| Surprise % | 1.08% | 1.14% | -13.28% | -0.29% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 10.62 | 10.17 | 34.49 | 39.58 |
| 7 Days Ago | 10.32 | 10.05 | 35.22 | 40.8 |
| 30 Days Ago | 10.2 | 10.02 | 35.23 | 40.76 |
| 60 Days Ago | 10.21 | 10.01 | 35.3 | 40.86 |
| 90 Days Ago | 10.36 | 10.2 | 36.21 | 41.62 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 7 | 7 | -- | 1 |
| Up Last 30 Days | 8 | 8 | 1 | 1 |
| Down Last 7 Days | 3 | 3 | 11 | 5 |
| Down Last 30 Days | 3 | 3 | 12 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ELV | -0.18% | 0.46% | 4.39% | 14.75% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Reiterates | Argus Research: Hold to Hold | 1/29/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/28/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/24/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/24/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Maintains | Mizuho: Outperform to Outperform | 11/5/2024 |
Related Tickers
HUM Humana Inc.
294.23
-2.93%
CI The Cigna Group
303.31
+0.16%
UNH UnitedHealth Group Incorporated
538.10
-0.81%
CVS CVS Health Corporation
56.90
-0.75%
CNC Centene Corporation
63.91
-1.25%
MOH Molina Healthcare, Inc.
304.28
-1.02%
OSCR Oscar Health, Inc.
16.68
+2.46%
CLOV Clover Health Investments, Corp.
4.4500
-3.05%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
NEUE NeueHealth, Inc.
7.34
-0.14%